Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 30;32(2):123-131.
doi: 10.5606/tgkdc.dergisi.2024.25700. eCollection 2024 Apr.

The intracranial effects of flow reversal during transcarotid artery revascularization

Busra Tok Cekmecelioglu  1   2   3 , Peter Legeza  1   4 , Pooja Tekula  1 , Martin Giesecke  5 , Charudatta S Bavare  1 , Zsolt Garami  1 , Alan Lumsden  1
Affiliations

The intracranial effects of flow reversal during transcarotid artery revascularization

Busra Tok Cekmecelioglu et al. Turk Gogus Kalp Damar Cerrahisi Derg. .

Abstract

Background: This study aimed to assess intraoperative cerebral hemodynamic responses and embolic events during transcarotid artery revascularization via transcranial Doppler, near-infrared spectroscopy, and bispectral index monitoring.

Methods: Twelve patients (7 males, 5 females; mean age: 72.8±9.0 years; range, 63 to 91 years) undergoing transcarotid artery revascularization with simultaneous transcranial Doppler, near-infrared spectroscopy, and bispectral index monitoring were analyzed in this retrospective study between September 2017 and December 2019. The mean flow velocity and pulsatility index of the middle cerebral artery, alongside near-infrared spectroscopy and bispectral index values, before flow reversal, during flow reversal, and after flow reversal phases were investigated. The presence and frequency of high-intensity transient signals were recorded to evaluate embolic incidents.

Results: Significant reductions in middle cerebral artery mean flow velocity were noted during flow reversal (40.58±10.57 cm/sec to 20.58±14.34 cm/sec, p=0.0004), which subsequently returned to and exceeded baseline values after flow reversal cessation (53.33±17.69 cm/sec, p=0.0005). Near-infrared spectroscopy (71±4.4% to 66±6.2%) and bispectral index (45.71±8.5 to 40.14±8.1) values mirrored these hemodynamic changes, with notable decreases during flow reversal, and recoveries after flow reversal. The highest concentration of high-intensity transient signals was observed during stent deployment, signifying a critical embolic phase. No perioperative neurological complications or other significant adverse events were documented.

Conclusion: Transcranial Doppler, near-infrared spectroscopy, and bispectral index effectively monitor cerebral hemodynamics and embolic potential during transcarotid artery revascularization, providing real-time data crucial for optimizing perioperative management. These findings underscore the clinical value of multimodal monitoring in improving patient outcomes in transcarotid artery revascularization procedures.

Keywords: Carotid artery disease; cerebral hemodynamics; neuroprotection systems; transcarotid artery revascularization; transcranial Doppler..

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Figures

Figure 1
Figure 1. Four-channel live case recordings for procedural phases, which included a TCD monitor, vital parameters, fluoroscopy images, and three-dimensional reconstructed CTA images. TCD: Transcranial Doppler; CTA: Computed tomography angiography; MCA: Middle cerebral artery; DSA: Digital subtraction angiography.
Figure 2
Figure 2. Mean number of high-intensity signals in phases.
See this image and copyright information in PMC

References

    1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2019 update: A report from the American Heart Association. e56-528Circulation. 2019;139 doi: 10.1161/CIR.0000000000000659. - DOI - PubMed
    1. O'Brien M, Chandra A. Carotid revascularization: Risks and benefits. Vasc Health Risk Manag. 2014;10:403–416. doi: 10.2147/VHRM.S48923. - DOI - PMC - PubMed
    1. Fisher M, Paganini-Hill A, Martin A, Cosgrove M, Toole JF, Barnett HJ, et al. Carotid plaque pathology: Thrombosis, ulceration, and stroke pathogenesis. Stroke. 2005;36:253–257. doi: 10.1161/01.STR.0000152336.71224.21. - DOI - PubMed
    1. North American Symptomatic Carotid Endarterectomy Trial Collaborators; Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ, Ferguson GG, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with highgrade carotid stenosis. N Engl J Med. 1991;325:445–453. doi: 10.1056/NEJM199108153250701. - DOI - PubMed
    1. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet. 2004;363:1491–1502. doi: 10.1016/S0140-6736(04)16146-1. - DOI - PubMed

LinkOut - more resources